domains/health/hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure.md

@@ -25,6 +25,12 @@ This provides the strongest single empirical case for the claim that medical car
 
 ---
 
+### Additional Evidence (extend)
+*Source: [[2024-xx-ajpm-cvd-mortality-trends-2010-2022-update-final-data]] | Added: 2026-03-31*
+
+US CVD age-adjusted mortality rate in 2022 returned to 2012 levels (434.6 per 100,000 for adults ≥35), erasing a decade of progress. Adults aged 35-54 experienced elimination of the preceding decade's CVD gains from 2019-2022, with 228,524 excess CVD deaths 2020-2022 (9% above expected). The midlife pattern is inconsistent with COVID harvesting (which primarily affects the frail elderly) and suggests structural disease load.
+
+
 Relevant Notes:
 - [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]
 - [[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]

inbox/queue/2024-xx-ajpm-cvd-mortality-trends-2010-2022-update-final-data.md

@@ -7,9 +7,13 @@ date: 2024-09-01
 domain: health
 secondary_domains: []
 format: article
-status: unprocessed
+status: enrichment
 priority: high
 tags: [CVD-mortality, cardiovascular, stagnation, midlife, working-age, excess-deaths, COVID, 2010-2022, AJPM]
+processed_by: vida
+processed_date: 2026-03-31
+enrichments_applied: ["hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -79,3 +83,12 @@ PRIMARY CONNECTION: `hypertension-related-cvd-mortality-doubled-2000-2023-despit
 WHY ARCHIVED: Closes the COVID harvesting test thread. Confirms the 2022 CVD AAMR is at 2012 levels with the 35-54 age group showing full decade erasure — key evidence for structural vs. transient interpretation of CVD stagnation.
 
 EXTRACTION HINT: This is a data update to the stagnation cluster, not a new standalone claim. The extractor should enrich the existing stagnation claims with the midlife 35-54 "decade of gains erased" finding. The PNAS "double jeopardy" framing (older-age more numerically significant than midlife) should be noted as a scope qualifier.
+
+
+## Key Facts
+- CVD AAMR declined 8.9% from 2010 to 2019 (456.6 → 413.0 per 100,000)
+- CVD AAMR increased 9.3% from 2019 to 2022 to 454.5 per 100,000
+- 2022 CVD AAMR for adults ≥35 was 434.6 per 100,000, matching 2012 levels (434.7)
+- 228,524 excess CVD deaths occurred 2020-2022, representing 9% above expected
+- All-cause mortality AAMR decreased 6.0% from 2022 to 2023 (798.8 → 750.5 per 100,000)
+- PNAS 2023 companion paper describes US experiencing 'double jeopardy' driven more by older-age than midlife mortality numerically